Dr. Bruce Levy is the Parker B. Francis Professor of Medicine at Harvard Medical School and Chief of the Pulmonary and Critical Care Medicine Division at Brigham and Women’s Hospital. Dr. Levy’s Airway Inflammation and Resolution “AIR” laboratory aims to identify new pathways to resolve pulmonary inflammation, infection or injury by understanding the roles of naturally-derived, specialized pro-resolving mediators in health, and then translating these findings to the pathobiology of important lung diseases, including ARDS. His work has helped lead to more than 200 peer-reviewed publications, over 10 patents awarded or pending, and continuous funding from the National Institutes of Health since 1993. He is an active participant in NIH grant review study sections. He is an elected member of the ASCI, AAP and Interurban Clinical Club. He is active in the American Thoracic Society and has served in several leadership roles for the ATS, including as Chair of the Publication Policy Committee and a member of the Board of Directors.
Thomas P. Loughran, Jr., MD, is the Director of the University of Virginia Cancer Center, F. Palmer Weber-Smithfield Foods Professor of Oncology Research and professor of medicine. Dr. Loughran’s career as a physician scientist is a testament to translational research with clinical observations leading to discoveries in the laboratory, and laboratory research contributing to improved clinical treatments. He was instrumental in the discovery of large granular lymphocyte (LGL) leukemia, and is considered the worldwide expert in this disease. He has published numerous articles in high-impact peer-reviewed journals including The New England Journal of Medicine, Annals of Internal Medicine, Lancet, Journal of Clinical Investigation, Journal of Clinical Oncology, and Blood.
From July 2003 to August 2013, Dr. Loughran served as the founding director of the Penn State Hershey Cancer Institute and professor of medicine at the Penn State College of Medicine. He previously served as program leader of hematologic malignancies at the H. Lee Moffitt Cancer Center and Research Institute at the University of South Florida, associate director of the Bone Marrow Transplant Program at SUNY Health Science Center and chief of hematology at the Syracuse Veteran's Affairs Medical Center in Syracuse, N.Y.
He completed his fellowship in medical oncology at the Fred Hutchinson Cancer Research Center under direction of Nobel Prize recipient Dr. E.D. Thomas and remained on the faculty there for seven years. Dr. Loughran’s ongoing research includes the establishment of the first LGL leukemia patient registry, the role of sphingolipid metabolism in leukemic LGL survival, understanding the genomic landscape of LGL leukemia, and developing new therapeutics for acute myelogenous leukemia with the use of nanotechnology drug delivery systems.
Copyright © 2019 Southeastern Regional Lipid Conference - All Rights Reserved.
Powered by Avanti Marketing